🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase 2a study to evaluate the safety and efficacy of ALV003 to treat cel...
Status
Completed
Location
Terveystalo Kuopio
Start Date
2010-11
Trial ID
NCT01255696
Treatments Being Tested
To determine the effects of 12 weeks administration of different dose level...
Status
Unknown
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01917630
ALV003-0812 is a study of the safety and tolerability of a study drug (ALV0...
Status
Completed
Location
Clinical Applications Laboratories, Inc.
Start Date
2008-03
Trial ID
NCT00669825
This is a Phase 0, Double-blind study that will assess the effect of in vit...
Status
Completed
Location
Nucleus Networks Limited
Start Date
2008-05
Trial ID
NCT00859391
Single Center, Randomized, Double-Blind, Placebo Controlled, Gluten Challen...
Status
Completed
Location
Mayo Clinic - 200 First Street SW
Start Date
2019-03-01
Trial ID
NCT03585478
Treatments Being Tested
This is a phase 2, single-center prospective, double-blind, placebo-control...
Status
Terminated
Location
Stanford University
Start Date
2021-04-06
Trial ID
NCT04839575
Treatments Being Tested
To assess safety and tolerability of ALV003 in healthy volunteers and patie...
Status
Completed
Location
Clinical Applications Laboratories Inc.
Start Date
2008-02
Trial ID
NCT00626184
Treatments Being Tested
This is a phase 2b, multicenter, prospective, randomized, double-blind, pla...
Status
Terminated
Location
Mayo Clinic
Start Date
2019-11-01
Trial ID
NCT04243551
Treatments Being Tested
A phase 2a study to evaluate the safety and efficacy of ALV003 to treat cel...
Status
Completed
Location
FINN-MEDI Research - Clinical Trials Center
Start Date
2009-08
Trial ID
NCT00959114
Treatments Being Tested